Ring-a-ring-a-roses: Bioterrorism and its peculiar relevance to pediatrics

Current Opinion in Pediatrics

Volumn 15, Issue 1, 2003, Pages 107-111

  Cieslak, Theodore J ^a,c   Henretig, Fred M ^b  

^a San Antonio Military Pediatric Center   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c BROOKE ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL WARFARE; GEOGRAPHIC DISTRIBUTION; PEDIATRICS; PLAGUE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RECOGNITION; REVIEW; VICTIM;

ADOLESCENT; ADULT; AGE FACTORS; BIOTERRORISM; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; PEDIATRICS; PREGNANCY;

EID: 0037305653     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200302000-00018     Document Type: Review

References (36)

1. Baring-Gould WS, Baring-Gould C: The annotated Mother Goose. New York, NY: Bramhall House; 1962:252-253.
2. Okumura T, Takasu N, Ishimatsu S, et al.: Report on 640 victims of the Tokyo subway sarin attack. Ann Emerg Med 1996, 28:129-135.
3. Torok TJ, Tauxe RV, Wise RP, et al.: A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars. JAMA 1997, 278:389-395.
4. American Academy of Pediatrics, Committee on Environmental Health and Committee on Infectious Diseases: Chemical-biological terrorism and its impact on children: a subject review. Pediatrics 2000, 105:662-670.
5. Cieslak TJ, Eitzen EM: Bioterrorism: agents of concern. J Public Health Manag Pract 2000, 6:19-29.
6. Centers for Disease Control and Prevention: Biological and chemical terrorism: strategic plan for preparedness and response. MMWR Morb Mortal Wkly Rep 2000, 49(RR-4):1-14.
7. Khan AS, Morse S, Lillibridge S: Public-health preparedness for biological terrorism in the USA. Lancet 2000, 356:117g-1182.
8. Johnson KM, Martin DH: Venezuelan equine encephalitis. Adv Vet Sci Comp Med 1974, 18:79.
9. Centers for Disease Control and Prevention: Update: pulmonary hemorrhage/hemosiderosis among infants- Cleveland, Ohio, 1993-1996. MMWR Morb Mortal Wkly Rep 2000, 49:180-184.
10. Centers for Disease Control and Prevention: Update: pulmonary hemorrhage/hemosiderosis among infants-Cleveland, Ohio, 1993-1996. MMWR Morb Mortal Wkly Rep 1997, 46:33-35.
11. Meselson M, Guillemin J, Hugh-Jones M, et al.: The Sverdlovsk anthrax outbreak of 1979. Science 1994,266:1202-1208.
12. Elkina AV: Epidemiology of a pulmonary form of anthrax. Zh Mikrobiol Epidemiol Immunobiol 1971, 48:112-116.
13. Elkin BT, Gates CC, Ellsworth T, et al.: Meso- and macro-ecology of anthrax in bison in Northern Canada: the 1993 MacKenzie outbreak as a case study [abstract]. In: Proceedings of the 3rd International Conference on Anthrax; September 1998; Plymouth, England.
14. Davies JCA: A major epidemic of anthrax in Zimbabwe: the experience at the Beatrice Road Infectious Diseases Hospital, Harare. Cent Afr J Med 1985, 31:176-180.
15. Arya LS, Saidali A, Qureshi MA, et al.: Anthrax in infants and children in Afghanistan. Indian J Pediatr 1982, 49:529-534.
16. Freedman A, Afonja O, Chang MW, et al.: Cutaneous anthrax associated with microangiopathic hemolytic anemia and coagulopathy in a 7-month-old infant. JAMA 2002, 287:869-874.
17. Dance DAB, Davis TME, Wattanagoon Y, et al.: Acute suppurative parotitis caused by Pseudomonas pseudomallei in children. J Infect Dis 1989, 159:654-660.
18. Inglesby TV, O'Toole T, Henderson DA, et al.: Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 2002, 287:2236-2252.
19. Centers for Disease Control and Prevention: Update: investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR Morb Mortal Wkly Rep 2001, 50:909-919.
20. Inglesby TV, Dennis DT, Henderson DA, et al.: Plague as a biological weapon: medical and public health management. JAMA 2000, 283:2281-2290.
21. Dennis DT, Inglesby TV, Henderson DA, et al.: Tularemia as a biological weapon: medical and public health management. JAMA 2002, 285:2763-2773.
22. Centers for Disease Control and Prevention: Update: interim recommendations for antimicrobial prophylaxis for children and breastfeeding mothers and treatment of children with anthrax. MMWR Morb Mortar Wkry Rep 2001, 50:1014-106.
23. Benavides S, Nahata MC: Anthrax: safe treatment for children. Ann Pharmacother 2002, 36:334-337.
24. Centers for Disease Control and Prevention: Additional options for preventive treatment for persons exposed to inhalational anthrax. MMWR Morb Mortal Wkly Rep 2001, 50:1142,1151.
25. Centers for Disease Control and Prevention: Prevention of plague: recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 1996, 45(RR-14):1-15.
26. Goldstein JA, Neff JM, Lane JM, et al.: Smallpox vaccination reactions, prophylaxis, and therapy of complications. Pediatrics 1975, 55:342-347.
27. Hiss J, Arensburg B: Suffocation from misuse of gas masks during the Gulf war. BMJ 1992, 304:92.
28. Amirav I, Epstein Y, Luder AS: Physiological and practical evaluation of a biological/chemical protective device for infants. Mil Med 2000, 165:663-666.
29. Epstein Y, Linder N, Lubin D, et al.: The incubator as a chemical warfare protective device in neonatal intensive care units. Isr J Med Sci 1991, 27:648-651.
30. Walk RD: The Mickey Mouse mask. Army Chem Rev 1999, PB 3-99-1.
31. Walk RD: We must protect the children. Army Chem Rev 1999, PB 3-99-2;25-9.
32. Havlak R, Gorman SE, Adams SA: Challenges associated with creating a pharmaceutical stockpile to respond to a terrorist event. Clin Microbiol Infect 2002, 8:529-533.
33. Henretig FM, Cieslak TJ, Madsen JM, et al.: The emergency department response to incidents of biological and chemical terrorism. In: Textbook of Pediatric Emergency Medicine. Edited by Fleisher GR, Ludwig S. Philadelphia, PA: Lippincott, Williams & Wilkins; 2000:1763-1784.
34. Patt HA, Feigin RD: Diagnosis and management of suspected cases of bioterrorism: a pediatric perspective. Pediatrics 2002, 109:685-692.
35. Henretig FM, Cieslak TJ, Eitzen EM: Medical progress: biological and chemical terrorism. J Pediatr 2002, 141:311-326.
36. White SR, Henretig FM, Dukes RG: Medical management of vulnerable populations and co-morbid conditions of victims of bioterrorism. Emerg Med Clin North Am 2002, 20:365-392.